(Total Views: 219)
Posted On: 03/05/2018 11:01:03 PM
Post# of 99141
$ETBI: .004 Filings out 03/01/18, company expects to be current on otcmarkets soon and uplist on Canadian Stock Exchange (CSE); this co-listing will lead to further non-dilutive financing, product development and very likely a licensing agreement. Additionally, the company says acquisition goals have been met:
1. Developed internal distribution avenue of EastGate's product lines
2. Add cash flowing assets contributing to the overall mission of EastGate
3. Generate cash flow that will stabilize public company expenses
4. Facility to conduct future R&D via clinical trials.
ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
1. Developed internal distribution avenue of EastGate's product lines
2. Add cash flowing assets contributing to the overall mission of EastGate
3. Generate cash flow that will stabilize public company expenses
4. Facility to conduct future R&D via clinical trials.
ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
